BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Özenver N, Efferth T. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases. Pharmacol Res 2021;170:105710. [PMID: 34089866 DOI: 10.1016/j.phrs.2021.105710] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang D, Wang T, Zhang Z, Li Z, Guo Y, Zhao G, Wu L. Recent advances in the effects of dietary polyphenols on inflammation in vivo: potential molecular mechanisms, receptor targets, safety issues, and uses of nanodelivery system and polyphenol polymers. Current Opinion in Food Science 2022;48:100921. [DOI: 10.1016/j.cofs.2022.100921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Sousa LFB, Oliveira HBM, das Neves Selis N, Morbeck LLB, Santos TC, da Silva LSC, Viana JCS, Reis MM, Sampaio BA, Campos GB, Timenetsky J, Yatsuda R, Marques LM. β-caryophyllene and docosahexaenoic acid, isolated or associated, have potential antinociceptive and anti-inflammatory effects in vitro and in vivo. Sci Rep 2022;12:19199. [DOI: 10.1038/s41598-022-23842-1] [Reference Citation Analysis]
3 Wang X, Wu F, Huang Y, Li H, Cao X, You Y, Meng Z, Sun K, Shen X. Matrine suppresses NLRP3 inflammasome activation via regulating PTPN2/JNK/SREBP2 pathway in sepsis. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154574] [Reference Citation Analysis]
4 El-sayed S, Freeman S, Bryce RA. A Selective Review and Virtual Screening Analysis of Natural Product Inhibitors of the NLRP3 Inflammasome. Molecules 2022;27:6213. [DOI: 10.3390/molecules27196213] [Reference Citation Analysis]
5 Asgharifar SF, Heris MJ. Role of the NLRP3-Q705K polymorphism in the pathogenesis of inflammatory-mediated diseases: A brief look at impacts of the Q705 polymorphism and NLRP3 activation on cancer immunotherapy. Human Gene 2022;33:201057. [DOI: 10.1016/j.humgen.2022.201057] [Reference Citation Analysis]
6 Yu J, Jiang Q, Liu N, Fan D, Wang M, Zhao Y. Apigenin and apigenin-7, 4'-O-dioctanoate protect against acrolein-aggravated inflammation via inhibiting the activation of NLRP3 inflammasome and HMGB1/MYD88/NF-κB signaling pathway in Human umbilical vein endothelial cells (HUVEC). Food Chem Toxicol 2022;:113400. [PMID: 36055550 DOI: 10.1016/j.fct.2022.113400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mansoor F, Jabeen A, Shah SF, Simjee SU, Bano S, Faizi S. In-vitro inhibition of NLRP3 inflammasome by 3,6-dihydroxyflavone (3,6-DHF): a therapeutic strategy for the treatment of chronic inflammatory and autoimmune diseases. Mol Cell Biochem 2022. [PMID: 35951149 DOI: 10.1007/s11010-022-04527-9] [Reference Citation Analysis]
8 Bakhshi S, Shamsi S. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes. International Immunopharmacology 2022;106:108595. [DOI: 10.1016/j.intimp.2022.108595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Wang JY, Xing Y, Li MY, Zhang ZH, Jin HL, Ma J, Lee JJ, Zhong Y, Zuo HX, Jin X. Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages. J Ethnopharmacol 2022;283:114715. [PMID: 34648898 DOI: 10.1016/j.jep.2021.114715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhou GQ, Chen G, Yang J, Qin WY, Ping J. Guizhi-Shaoyao-Zhimu decoction attenuates monosodium urate crystal-induced inflammation through inactivation of NF-κB and NLRP3 inflammasome. J Ethnopharmacol 2022;283:114707. [PMID: 34619319 DOI: 10.1016/j.jep.2021.114707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bertinaria M. Inflammasome Inhibitors. Molecules 2021;26:6912. [PMID: 34834004 DOI: 10.3390/molecules26226912] [Reference Citation Analysis]
12 Chen X, Zhang D, Li Y, Wang W, Bei W, Guo J. NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe? Pharmacol Res 2021;173:105885. [PMID: 34536551 DOI: 10.1016/j.phrs.2021.105885] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]